1. Digenis, G.A., “Radionuclide Imaging in Drug Research,” Ed. by Wilson, C.G., Hardy, J.G., Frier, M., Davis, S.S. (1982) Croom Helm, London; Chapter 9, The Utilization of Short-Lived Radionuclides in the Assessment of Formulation and In Vivo Disposition of Drugs, p. 103–144.
2. Casey, D.L., Beihn, R.M., Digenis, G.A., Shambhu, M.B., Method of Monitoring Hard Gelatin Capsule Disintegration Times in Humans Using External Scintigraphy, J. Pharm. Sci. 65:1412–1413 (1976).
3. Daly, P.B., Davis, S.S., Frier, M., Hardy, J.G., Kennerley, J.W., Wilson, C.G., Scintigraphic Assessment of the In Vivo Dissolution Rate of a Sustained Release Tablet, Int. J. Pharm.10:17–24 (1982).
4. Humphrey, M.J., Brewster, D., McLeary, M.A., “Radionuclide Imaging in Drug Research,” cf supra; Chapter 19.6, Studies on the Systemic Bioavailability of Buprenorphine by Various Routes of Administration, p. 301–303.
5. Tupper, C.H., Copping, N., Thomas, N.W., Wilson, C.G., Ibid. Chapter 19.12, Spreading of Suppository Bases Assessed with Histological and Scintigraphic Techniques, p. 322–324.